Biofil Chemicals & Pharmaceuticals Ltd.

•

biofilgroup.netBSE: 524396NSE: BIOFILCHEM

Market Cap₹ 52 Cr.

Current Price

High / Low₹ 46 / 26

Stock P/E107.0

Book Value₹ 13

Price to Book1.95

Dividend Yield0.00 %

ROCE15.8 %

ROE13.8 %

Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2026 • Pharma Unit: 66.8% • Chemicals Div.: 33.2%

AI Sector View

AI GENERATED

Oil Gas & Consumable Fuels

Reduce

Sector economics are clouded by input volatility and uneven volume trends. WPI fuel inflation is very high at 20.05% (Jul/26), crude oil output is -5.3% YoY (2026-07), natural gas is -3.7% YoY (2026-07), and natural gas consumption is -3.0% YoY (2026-06), although refinery products grew 2.7% YoY (2026-07) and coal was 7.6% YoY (2026-07). Heavy FPI outflows of INR -15293 crore over 3 months to 2026-08-31 and negative oil-linked news flow reinforce the underweight.

Confidence

78%

View full sector analysis →

PROS

Company comfortably covers its interest (342.5x coverage)
Company generates healthy free cash flow
Company maintains a comfortable, low leverage position

CONS

Recent results are weak - TTM profit is down 90.8% versus prior year
A large part of profit comes from other income (89.4% of PBT)
Operating cash flow has been negative in recent years
Company has a low return on capital employed of 8.3%
Company has a low return on equity of 6.9% over last 3 years
Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -0.03x)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

Oil Gas & Consumable FuelsTradingTrading

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	ADANIENT	2936.00	53.39	397452.96	0.04	-1461.54	-249.67	32923.98	49.92	13.30	15.57
2.	PREMIERENE	998.00	27.21	45304.36	0.10	471.92	53.32	2462.59	35.25	33.72	29.03
3.	AEGISLOG	1270.55	35.64	44596.31	0.68	544.84	210.70	2356.86	37.07	19.76	30.28
4.	CPPLUS	3705.90	91.86	43840.96	0.04	142.20	332.51	1402.42	89.51	29.48	14.52
5.	REDINGTON	371.40	17.07	29035.10	1.62	453.49	94.65	34922.47	34.57	18.96	2.03
6.	HONASA	470.75	61.67	15347.59	0.64	90.45	118.87	755.95	27.00	8.99	14.58
7.	LLOYDSENT	74.20	100.87	11327.02	0.20	109.98	-55.77	563.03	70.15	12.84	18.07
8.	SGMART	826.10	83.74	10411.77	0.00	455.80	1310.71	13085.70	1044.08	10.43	4.49
9.	MMTC	64.18	21.52	9627.00	0.00	104.24	135.52	0.68	-50.00	33.46	-1423.53
10.	ENTERO	1827.20	63.41	7952.54	0.00	52.05	72.17	1940.50	38.23	10.93	5.00
11.	CELLO	342.50	24.69	7724.69	0.44	73.40	-8.99	526.72	-0.43	17.15	18.80
12.	BIOFILCHEM	31.70	107.03	51.59	0.00	0.11	-95.48	12.35	92.07	15.78	1.13

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	2	17	5	15	8	2	14	8	6	14	1	8	12
	2	17	5	15	8	2	14	8	6	13	1	7	12
Operating Profit	0	0	0	-0	0	0	0	0	0	0	0	0	0
OPM %	16.87%	1.38%	3.78%	-0.26%	3.55%	4.98%	2.18%	1.32%	0.00%	0.81%	11.63%	5.81%	0.57%
	0	0	0	0	0	0	0	0	3	0	0	0	0
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0
Profit before Tax	0	0	0	0	0	0	0	0	3	0	0	0	0
Tax %	25.00%	20.00%	18.18%	11.11%	26.09%	33.33%	27.27%	20.00%	12.68%	27.27%	27.27%	55.32%	18.66%
Net Profit	0	0	0	0	0	0	0	0	2	0	0	0	0
	0.15	0.08	0.06	0.15	0.10	0.01	0.10	0.12	1.48	0.05	0.05	0.13	0.07

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	13	12	23	30	36	22	30	40	33	28	34
	11	11	22	28	34	21	29	39	33	28	34
Operating Profit	3	1	1	2	2	1	1	1	1	1	1
OPM %	19.48%	7.57%	4.43%	6.14%	4.47%	5.95%	3.89%	2.04%	2.54%	2.29%	2.10%
	0	0	0	0	1	0	0	0	0	3	0
Interest	0	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0	0
Profit before Tax	2	1	1	1	2	1	1	1	1	3	1
Tax %	22.34%	19.98%	19.39%	17.55%	35.31%	31.19%	29.33%	18.04%	24.24%	19.24%	41.87%
Net Profit	2	0	0	1	1	1	1	1	1	3	0
EPS	0.00	0.00	0.00	0.00	0.77	0.44	0.34	0.44	0.34	1.71	—
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	—

COMPOUNDED SALES GROWTH

10 Years:: 8%
5 Years:: -5%
3 Years:: -2%

COMPOUNDED PROFIT GROWTH

10 Years:: 14%
5 Years:: 18%
3 Years:: 71%

STOCK PRICE CAGR

10 Years:: —
5 Years:: -13%
3 Years:: -14%
1 Year:: -26%

RETURN ON EQUITY

10 Years:: 7%
5 Years:: 6%
3 Years:: 7%
Last Year:: 14%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	16	16	16	16	16	16	16	16	16	16
	-4	-3	-3	-1	-0	1	1	2	3	5
	1	2	2	1	0	0	1	0	0	3
Trade Payables	7	9	9	26	16	1	13	28	31	17
	1	0	0	0	1	1	1	1	1	1
Total Liabilities	22	24	24	42	33	19	31	47	51	43
	9	9	10	10	10	9	9	9	8	7
	0	1	1	2	4	1	1	3	3	4
	0	0	0	0	0	0	0	33	38	28
Cash & Bank	0	0	0	0	0	0	0	2	0	3
	12	14	13	30	19	8	21	1	1	1
Total Assets	22	24	24	42	33	19	31	47	51	43

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	1	1	1	1	2	0	0	2	-2	-1
Cash from Investing	-0	-0	-1	-0	-0	-0	-0	-0	-0	1
Cash from Financing	-0	-0	-0	-1	-1	-0	0	-0	-0	3
	0	0	-0	0	0	-0	-0	2	-2	3

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
PER SHARE
EPS (₹)	1.10	0.29	0.30	0.74	0.76	0.43	0.34	0.44	0.34	1.71
Book Value (₹)	7.80	8.09	8.39	9.15	9.91	10.35	10.63	11.19	11.54	13.25
Dividend per Share (₹)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash EPS (₹)	1.28	0.47	0.52	0.99	1.02	0.69	0.61	0.68	0.58	1.88
PROFITABILITY
Operating Margin %	20.50%	8.39%	4.86%	6.72%	6.71%	6.63%	4.21%	2.04%	2.54%	2.29%
Net Margin %	13.34%	3.81%	2.09%	4.07%	3.47%	3.12%	1.87%	1.77%	1.67%	9.81%
ROE %	18.09%	3.64%	3.60%	8.46%	8.01%	4.24%	3.28%	4.00%	3.02%	13.81%
ROCE %	21.86%	5.13%	5.06%	10.12%	12.18%	6.23%	4.76%	4.97%	4.08%	15.78%
	7.81%	2.05%	1.99%	3.63%	3.28%	2.69%	2.24%	1.81%	1.14%	5.94%
EFFICIENCY
Debtor Days	345	361	197	257	240	199	168	244	390	424
Inventory Days	4	18	17	18	31	46	15	17	32	47
Payable Days	401	303	162	249	235	154	88	196	346	338
	-52	75	53	25	35	91	95	66	76	133
FINANCIAL HEALTH
Debt to Equity (x)	0.11x	0.12x	0.12x	0.08x	0.03x	0.03x	0.03x	0.02x	0.03x	0.14x
Interest Coverage (x)	15.12x	4.86x	4.70x	12.96x	29.18x	26.00x	19.66x	21.85x	20.95x	342.54x
	1.39x	1.36x	1.32x	1.17x	1.40x	6.23x	1.63x	1.35x	1.34x	1.73x
GROWTH
Revenue Growth %	2.15%	-8.13%	87.12%	28.37%	20.41%	-37.39%	34.19%	33.29%	-16.57%	-14.99%
Operating Profit Growth %	97.37%	-62.41%	8.49%	77.33%	20.26%	-38.18%	-14.73%	3.29%	-11.76%	223.76%
Net Profit Growth %	129.25%	-73.77%	2.46%	150.30%	2.83%	-43.74%	-19.76%	26.55%	-21.36%	399.55%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	26.54%	-21.36%	399.56%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	138.50x	120.02x	15.12x
P/B (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	5.40x	3.56x	1.95x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	73.79x	58.26x	11.20x

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	46.82	46.82	46.82	46.82	46.82	46.79	46.79	46.79	46.79
FIIs	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	0.08	0.08	0.08	0.08	0.08	0.08	0.08	0.08	0.08
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	53.10	53.10	53.10	53.10	53.10	53.13	53.13	53.13	53.13

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-08-28

Copy of Newspaper Publication

2026-08-28 - Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication Pursuant to Regulation 30, 44 and 47 of SEBI (LODR) Regulations, 2015 and in compliance with section 108 of the Companies Act, 2013 read with rule 20 of the Companies (Management and Administration) Rules, 2014.

2026-08-26

General Updates

2026-08-26 - Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about about intimation of e-voting for 41st Annual General Meeting

2026-08-26

General Updates

2026-08-26 - Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about draft letter to be dispatched to members whose email addresses not registered with the company/ depository participants

2026-08-26

Shareholders meeting

2026-08-26 - Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 23, 2026

2026-08-19

Copy of Newspaper Publication

2026-08-19 - Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication of Notice of 41st AGM through Video Conferencing ( VC )/ Other Audio Visual Means ( OAVM )

2026-08-12

Copy of Newspaper Publication

2026-08-12 - Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-11

Change in Management

2026-08-11 - Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Continuation of directorship of Mr. Ashok Kumar Ramawat (DIN: 08818263) as a Non-Executive Independent Director of the Company notwithstanding attaining the age of 75 (seventy-five) years

2026-08-11

Outcome of Board Meeting

2026-08-11 - Biofil Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

2026-07-01

Certificate under SEBI (Depositories and Participants) Regulations, 2018

2026-07-01 - Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

News

Recent coverage and analyst commentary for BIOFILCHEM

Loading news…

🤖

AI Stock Analyst

Biofil Chemicals & Pharmaceuticals Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

ADANIENT

2936.00

53.39

397452.96

0.04

-1461.54

-249.67

32923.98

49.92

13.30

15.57

PREMIERENE

998.00

27.21

45304.36

0.10

471.92

53.32

2462.59

35.25

33.72

29.03

AEGISLOG

1270.55

35.64

44596.31

0.68

544.84

210.70

2356.86

37.07

19.76

30.28

CPPLUS

3705.90

91.86

43840.96

0.04

142.20

332.51

1402.42

89.51

29.48

14.52

REDINGTON

371.40

17.07

29035.10

1.62

453.49

94.65

34922.47

34.57

18.96

2.03

HONASA

470.75

61.67

15347.59

0.64

90.45

118.87

755.95

27.00

8.99

14.58

LLOYDSENT

74.20

100.87

11327.02

0.20

109.98

-55.77

563.03

70.15

12.84

18.07

SGMART

826.10

83.74

10411.77

0.00

455.80

1310.71

13085.70

1044.08

10.43

4.49

MMTC

64.18

21.52

9627.00

0.00

104.24

135.52

0.68

-50.00

33.46

-1423.53

ENTERO

1827.20

63.41

7952.54

0.00

52.05

72.17

1940.50

38.23

10.93

5.00

CELLO

342.50

24.69

7724.69

0.44

73.40

-8.99

526.72

-0.43

17.15

18.80

BIOFILCHEM

31.70

107.03

51.59

0.00

0.11

-95.48

12.35

92.07

15.78

1.13

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

Operating Profit

-0

OPM %

16.87%

1.38%

3.78%

-0.26%

3.55%

4.98%

2.18%

1.32%

0.00%

0.81%

11.63%

5.81%

0.57%

Interest

Depreciation

Profit before Tax

Tax %

25.00%

20.00%

18.18%

11.11%

26.09%

33.33%

27.27%

20.00%

12.68%

27.27%

55.32%

18.66%

Net Profit

0.15

0.08

0.06

0.15

0.10

0.01

0.10

0.12

1.48

0.05

0.13

0.07

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

TTM

Operating Profit

OPM %

19.48%

7.57%

4.43%

6.14%

4.47%

5.95%

3.89%

2.04%

2.54%

2.29%

2.10%

Interest

Depreciation

Profit before Tax

Tax %

22.34%

19.98%

19.39%

17.55%

35.31%

31.19%

29.33%

18.04%

24.24%

19.24%

41.87%

Net Profit

EPS

0.00

0.77

0.44

0.34

0.44

0.34

1.71

—

Dividend Payout %

0.00%

—

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Equity Capital

-4

-3

-1

-0

Trade Payables

Total Liabilities

Cash & Bank

Total Assets

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

-2

-1

Cash from Investing

-0

-1

-0

Cash from Financing

-0

-1

-0

-2

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

PER SHARE

EPS (₹)

1.10

0.29

0.30

0.74

0.76

0.43

0.34

0.44

0.34

1.71

Book Value (₹)

7.80

8.09

8.39

9.15

9.91

10.35

10.63

11.19

11.54

13.25

Dividend per Share (₹)

0.00

Cash EPS (₹)

1.28

0.47

0.52

0.99

1.02

0.69

0.61

0.68

0.58

1.88

PROFITABILITY

Operating Margin %

20.50%

8.39%

4.86%

6.72%

6.71%

6.63%

4.21%

2.04%

2.54%

2.29%

Net Margin %

13.34%

3.81%

2.09%

4.07%

3.47%

3.12%

1.87%

1.77%

1.67%

9.81%

ROE %

18.09%

3.64%

3.60%

8.46%

8.01%

4.24%

3.28%

4.00%

3.02%

13.81%

ROCE %

21.86%

5.13%

5.06%

10.12%

12.18%

6.23%

4.76%

4.97%

4.08%

15.78%

7.81%

2.05%

1.99%

3.63%

3.28%

2.69%

2.24%

1.81%

1.14%

5.94%

EFFICIENCY

Debtor Days

345

361

197

257

240

199

168

244

390

424

Inventory Days

Payable Days

401

303

162

249

235

154

196

346

338

-52

133

FINANCIAL HEALTH

Debt to Equity (x)

0.11x

0.12x

0.08x

0.03x

0.02x

0.03x

0.14x

Interest Coverage (x)

15.12x

4.86x

4.70x

12.96x

29.18x

26.00x

19.66x

21.85x

20.95x

342.54x

1.39x

1.36x

1.32x

1.17x

1.40x

6.23x

1.63x

1.35x

1.34x

1.73x

GROWTH

Revenue Growth %

2.15%

-8.13%

87.12%

28.37%

20.41%

-37.39%

34.19%

33.29%

-16.57%

-14.99%

Operating Profit Growth %

97.37%

-62.41%

8.49%

77.33%

20.26%

-38.18%

-14.73%

3.29%

-11.76%

223.76%

Net Profit Growth %

129.25%

-73.77%

2.46%

150.30%

2.83%

-43.74%

-19.76%

26.55%

-21.36%

399.55%

0.00%

26.54%

-21.36%

399.56%

VALUATION

P/E (x)

0.00x

138.50x

120.02x

15.12x

P/B (x)

0.00x

5.40x

3.56x

1.95x

Dividend Yield %

0.00%

0.00x

73.79x

58.26x

11.20x

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

46.82

46.79

FIIs

0.00

0.08

Government

0.00

53.10

53.13

Biofil Chemicals & Pharmaceuticals Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Biofil Chemicals & Pharmaceuticals Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI